Melanoma
A Randomized, Controlled, Multicenter, Phase 3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination with Nivolumab Versus Treatment of Physicians Choice in Patients with Advanced Melanoma That Has Progressed on an Anti-PD-1 and an Anti-CTLA-4 Containing Treatment Regimen [IGNYTE-3] (RP1-104)
- Details
ClinicalTrials.gov ID:
NCT06264180
Diagnosis Type:
NA
USOR Number:
- Address
,
P: